Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Androgen-Independent Prostatic Cancer

capecitabine has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Friberg, LE; Karlsson, MO; Koopman, M; Netterberg, I; Punt, CJA; Terstappen, LWMM1

Other Studies

1 other study(ies) available for capecitabine and Androgen-Independent Prostatic Cancer

ArticleYear
Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 09-15, Volume: 26, Issue:18

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cell Count; Cetuximab; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Feasibility Studies; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Models, Biological; Multicenter Studies as Topic; Neoplastic Cells, Circulating; Oxaliplatin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Response Evaluation Criteria in Solid Tumors; Risk Assessment; Tumor Burden

2020